Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 62.83B | 62.75B | 61.86B | 60.53B | 57.35B | 55.18B |
Gross Profit | 35.84B | 35.55B | 34.30B | 32.69B | 31.49B | 30.86B |
EBITDA | 12.33B | 12.18B | 14.69B | 7.17B | 12.41B | 10.55B |
Net Income | 5.47B | 6.02B | 7.50B | 1.64B | 5.74B | 5.59B |
Balance Sheet | ||||||
Total Assets | 145.67B | 137.18B | 135.24B | 127.24B | 132.00B | 155.97B |
Cash, Cash Equivalents and Short-Term Investments | 17.46B | 14.59B | 13.44B | 8.74B | 7.25B | 13.81B |
Total Debt | 66.83B | 58.40B | 59.94B | 54.01B | 55.14B | 65.09B |
Total Liabilities | 118.71B | 109.78B | 112.63B | 105.22B | 113.00B | 135.25B |
Stockholders Equity | 26.88B | 27.31B | 22.53B | 21.94B | 18.90B | 20.60B |
Cash Flow | ||||||
Free Cash Flow | 11.94B | 11.76B | 12.12B | 8.46B | 10.03B | 14.97B |
Operating Cash Flow | 13.65B | 13.45B | 13.93B | 10.44B | 12.80B | 18.20B |
Investing Cash Flow | -13.71B | -4.94B | -7.07B | -4.20B | -5.97B | -3.03B |
Financing Cash Flow | -3.51B | -7.08B | -1.77B | -4.96B | -13.35B | -9.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $78.03B | 24.28 | 29.00% | 2.78% | 3.85% | -0.38% | |
77 Outperform | $201.01B | 23.52 | 27.27% | 2.00% | 6.21% | 14.87% | |
75 Outperform | $269.25B | 49.83 | 21.91% | 2.32% | 1.23% | -33.87% | |
72 Outperform | $32.41B | 20.46 | 16.62% | 1.01% | -2.83% | 106.18% | |
71 Outperform | $38.32B | 16.37 | 16.61% | 1.59% | 4.09% | 14.05% | |
71 Outperform | $42.45B | 50.54 | 5.25% | 1.98% | -9.12% | ― | |
69 Neutral | ¥231.71B | 14.67 | 7.64% | 2.71% | 9.09% | 8.52% |
On June 20, 2025, IBM announced amendments to its existing credit agreements, extending the maturity of its $2.5 billion Three-Year Credit Agreement to June 20, 2028, and its $7.5 billion Five-Year Credit Agreement to June 22, 2030. These amendments, involving major financial institutions like JPMorgan Chase Bank, BNP Paribas, Citibank, and Royal Bank of Canada, are expected to provide IBM with enhanced financial flexibility and stability, potentially impacting its operational strategies and market positioning.
The most recent analyst rating on (IBM) stock is a Buy with a $200.00 price target. To see the full list of analyst forecasts on International Business Machines stock, see the IBM Stock Forecast page.
IBM reported strong financial performance for the first quarter of 2025, exceeding expectations with solid revenue growth, profitability, and cash flow generation. The company’s strategy around hybrid cloud and AI continues to drive success, with significant contributions from its software segment, particularly in automation and AI. IBM’s infrastructure segment also showed strong performance, and the company remains optimistic about its future growth prospects, maintaining its full-year guidance for revenue growth and free cash flow.